Submitted by web@researchtop... on Wed, 04/10/2013 - 12:23
Submitted by web@researchtop... on Fri, 04/05/2013 - 14:35
Submitted by web@researchtop... on Fri, 04/05/2013 - 14:31
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:53
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:41
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:34
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:22
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:17
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:10
Submitted by web@researchtop... on Fri, 04/05/2013 - 13:05
Submitted by web@researchtop... on Thu, 04/04/2013 - 16:08
Submitted by web@researchtop... on Thu, 03/07/2013 - 13:32
COMFORT-I: Updated Overall Survival Analysis by JAK2V617F Mutation Status
Back to 5MJC main page
Submitted by web@researchtop... on Mon, 03/04/2013 - 14:12
Submitted by web@researchtop... on Mon, 03/04/2013 - 13:18
Submitted by web@researchtop... on Tue, 02/26/2013 - 17:27
Ibrutinib/Rituximab: Computed Tomography at 3-6 Months (n = 31)
Back to 5MJC main page